Supreme court to review immunity of Sacklers from prosecution under a 2019 bankruptcy settlement with the OxyContin maker
The US supreme court will hear oral arguments on Monday on whether members of the wealthy Sackler family can receive immunity from civil prosecution under a 2019 bankruptcy deal agreed on with Purdue Pharma, the former manufacturer of prescription painkiller OxyContin.
Under a court reorganization plan, Sackler family members who controlled the Oxycontin maker were granted immunity and did not have to declare personal bankruptcy in exchange for a $6bn settlement, paid out over 10 years, to a fund created to offset costs created by the opioid dependency crisis that has cost hundreds of thousands of lives.
About Author
More Stories
Italy seeks to protect restaurants and hotels from fake and paid-for reviews
Bodies recovered from illegal goldmine in South Africa where many feared dead
‘Don’t allow you to go to the bathroom’: big tech’s call center workers in Greece on strike